These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6352616

  • 1. Evaluation of ceftazidime in the treatment of severe bacterial infection.
    Bouza E, Hellín T, Sanz-Hospital J, Rodríguez-Creixems M, Loza E, Martínez-Beltrán J.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():153-9. PubMed ID: 6352616
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of lamoxactam in the treatment of severe bacterial infections.
    Bouza E, Martínez-Beltrán J, Rodríguez-Creixems M, Loza E, Pérez del Rio J, Guerrero A, Hospital JS.
    Chemotherapy; 1983 Jul; 29(5):373-83. PubMed ID: 6617297
    [Abstract] [Full Text] [Related]

  • 3. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
    Pechère JC, Delisle R.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
    [Abstract] [Full Text] [Related]

  • 4. Ceftazidime in the therapy of serious Gram-negative bacillary infections.
    Pottage JC, Karakusis PH, Fliegelman RM, Levin S, Trenholme GM.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():223-8. PubMed ID: 6352623
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of aztreonam in the treatment of severe bacterial infections.
    Romero-Vivas J, Rodríguez-Créixems M, Bouza E, Hellín T, Guerrero A, Martínez-Beltrán J, García de la Torre M.
    Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832
    [Abstract] [Full Text] [Related]

  • 6. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P, Clément M, Geroulanos S, von Graevenitz A, Luthy R, Regamey C, Stalder H, Vogt M, Waldvogel FA.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.
    Scully BE, Neu HC.
    Arch Intern Med; 1984 Jan; 144(1):57-62. PubMed ID: 6419690
    [Abstract] [Full Text] [Related]

  • 9. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
    Sifuentes-Osornio J, Macías A, Amieva RI, Ramos A, Ruiz-Palacios GM.
    Am J Med; 1989 Nov 30; 87(5A):202S-205S. PubMed ID: 2686425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical experience with ceftazidime in urology in Japan.
    Kawamura N.
    J Antimicrob Chemother; 1983 Jul 30; 12 Suppl A():65-70. PubMed ID: 6352657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ceftazidime: a new approach in the treatment of moderate and severe infections.
    Abbas AM, Taylor MC, Newby D, Jones RB, Rigby CC, Haste AR, Cantor AM.
    J Antimicrob Chemother; 1983 Jul 30; 12 Suppl A():147-52. PubMed ID: 6352615
    [Abstract] [Full Text] [Related]

  • 15. Low-dosage cefepime as treatment for serious bacterial infections.
    Giamarellou H.
    J Antimicrob Chemother; 1993 Nov 30; 32 Suppl B():123-32. PubMed ID: 8150755
    [Abstract] [Full Text] [Related]

  • 16. Ceftazidime therapy for serious infections.
    Bint AJ, Constable J, Patton KR, Constable FL.
    J Antimicrob Chemother; 1983 Jul 30; 12 Suppl A():115-21. PubMed ID: 6352613
    [Abstract] [Full Text] [Related]

  • 17. Ciprofloxacin in patients with bacteremic infections. The Spanish Group for the Study of Ciprofloxacin.
    Bouza E, Díaz-López MD, Bernaldo de Quirós JC, Rodríguez-Créixems M.
    Am J Med; 1989 Nov 30; 87(5A):228S-231S. PubMed ID: 2589366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ceftazidime, as a single antibiotic, in the treatment of multi-resistant Gram-negative infections in intensive care.
    Gasparetto A, Delogu G.
    J Antimicrob Chemother; 1983 Jul 30; 12 Suppl A():171-5. PubMed ID: 6352617
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.